TCH-165,1446350-60-2

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

TCH-165

CAS No. : 1446350-60-2

MCE 国际站：TCH-165

产品活性：TCH-165 是蛋白酶体组装的小分子调节剂，可增加 20S 水平并促进 20S 介导的蛋白质降解。

研究领域：Metabolic Enzyme/Protease

作用靶点：Proteasome

In Vitro: TCH-165 (0.01-10 μM; 72 hours; RPMI8226 and U87MG cells) treatment inhibits cell growth of RPMI8226 and U87MG cells with IC₅₀ of 1.6 μM and 2.4 μM, respectively.
?TCH-165 (0-10 μM; 24 hours; HEK293T cells) treatment enhances ODC degradation is blocked by BTZ indicated that this event is proteasome-mediated. TCH-165 enhances proteolytic degradation in a concentration-dependent manner.
?TCH-165 enhances the chymotrypsin-like (CT-L), trypsin-like (Tryp-L) and caspase-like (Casp-L) activities with EC₅₀s of 4.2 μM, 3.2 μM and 4.7 μM, respectively.
?TCH-165 enhances 20S-mediated degradation of IDPs, α-syn, and tau in vitro, and does not induce the degradation of structured proteins such as GAPDH.
?TCH-165-treated cells display a decrease in the assembled 26S and an increase in the 20S proteasome. TCH-165 regulates the dynamic equilibrium between the 20S and 26S proteasome complexes, favoring 20S-mediated protein degradation.

相关产品：Bioactive Compound Library Plus  |  Metabolism/Protease Compound Library  |  Anti-Cancer Compound Library  |  Ubiquitination Compound Library  |  Targeted Diversity Library  |  MG-132  |  Bortezomib  |  Carfilzomib  |  Celastrol  |  Ixazomib  |  Epoxomicin  |  Isoginkgetin  |  Calpeptin  |  ONX-0914  |  PD150606  |  MG-101  |  Marizomib  |  Capzimin  |  MDL-28170  |  18α-Glycyrrhetinic acid  |  Oprozomib  |  K-7174 dihydrochloride  |  Aclacinomycin A hydrochloride  |  Delanzomib  |  PD 151746  |  Zetomipzomib maleate  |  Isovalerylcarnitine  |  KZR-504  |  M3258  |  RA190  |  Tomatine  |  Alicapistat

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds